PACS Group (NYSE:PACS) Stock Falls 7.6% - Here's Why

PACS Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • PACS Group shares fell 7.6% to about $42.80, while trading volume was 84% below its average; the article does not identify a specific catalyst for the drop.
  • The company beat quarterly estimates, reporting earnings of $0.63 per share versus $0.58 expected and revenue of $1.50 billion versus $1.46 billion expected.
  • Analyst sentiment remains broadly positive, with a “Moderate Buy” consensus and a $62.50 average price target. Insiders sold about $67.4 million in shares last quarter, including sales by the CEO and COO under pre-arranged plans.
  • Interested in PACS Group? Here are five stocks we like better.

PACS Group, Inc. (NYSE:PACS - Get Free Report)'s share price dropped 7.6% on Thursday. The stock traded as low as $43.24 and last traded at $42.7970. 142,318 shares were traded during trading, a decline of 84% from the average session volume of 887,698 shares. The stock had previously closed at $46.30.

Analysts Set New Price Targets

PACS has been the subject of several recent analyst reports. Truist Financial reaffirmed a "buy" rating and set a $65.00 price objective (up from $62.00) on shares of PACS Group in a report on Thursday, November 5th. Oppenheimer increased their price target on PACS Group from $48.00 to $57.00 and gave the stock an "outperform" rating in a research report on Monday, August 10th. Weiss Ratings upgraded PACS Group from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, November 4th. JPMorgan Chase & Co. raised their price target on PACS Group from $47.00 to $58.00 and gave the company an "overweight" rating in a report on Friday, September 4th. Finally, Zacks Research downgraded PACS Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, September 9th. Seven analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, PACS Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $62.50.

View Our Latest Research Report on PACS Group

PACS Group Stock Down 6.9%

The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.80 and a current ratio of 0.80. The stock has a market cap of $6.84 billion, a price-to-earnings ratio of 24.36, a PEG ratio of 1.58 and a beta of -0.14. The firm's 50-day simple moving average is $45.51 and its two-hundred day simple moving average is $40.58.

PACS Group (NYSE:PACS - Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.58 by $0.05. PACS Group had a net margin of 4.87% and a return on equity of 31.98%. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.46 billion. On average, sell-side analysts expect that PACS Group, Inc. will post 2.05 EPS for the current fiscal year.

Insider Buying and Selling

In other PACS Group news, COO Joshua Jergensen sold 40,000 shares of the stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $43.13, for a total value of $1,725,200.00. Following the transaction, the chief operating officer directly owned 2,496,320 shares in the company, valued at approximately $107,666,281.60. This trade represents a 1.58% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 167,434 shares of PACS Group stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $50.24, for a total value of $8,411,884.16. Following the completion of the sale, the chief executive officer directly owned 53,954,101 shares of the company's stock, valued at $2,710,654,034.24. This trade represents a 0.31% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,454,244 shares of company stock worth $67,394,064 in the last quarter. Insiders own 70.10% of the company's stock.

Hedge Funds Weigh In On PACS Group

Hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its holdings in PACS Group by 370.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company's stock worth $25,051,000 after purchasing an additional 614,250 shares during the last quarter. Sei Investments Co. boosted its stake in shares of PACS Group by 7.4% in the 1st quarter. Sei Investments Co. now owns 370,501 shares of the company's stock valued at $11,900,000 after purchasing an additional 25,462 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of PACS Group by 44.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company's stock worth $9,274,000 after buying an additional 89,067 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of PACS Group during the 2nd quarter worth approximately $8,196,000. Finally, Corient Private Wealth LP raised its stake in shares of PACS Group by 1.8% during the second quarter. Corient Private Wealth LP now owns 152,846 shares of the company's stock worth $6,517,000 after buying an additional 2,680 shares during the last quarter.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in PACS Group Right Now?

Before you consider PACS Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.

While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines